Aradigm (United States)

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial

David J. Serisier, Diana Bilton, Anthony De Soyza et al. · Thorax · 2013 · 243 citations · Full text

Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆

Pradipta Chattopadhyay, Boris Y. Shekunov, DaBin Yim et al. · Advanced Drug Delivery Reviews · 2007 · 221 citations

Lipid Preparation, Aerx System☆, Pulmonary Delivery +5

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials

Charles Haworth, Diana Bilton, James D. Chalmers et al. · The Lancet Respiratory Medicine · 2019 · 198 citations · Full text

Non-cystic Fibrosis Bronchiectasis, Inflammatory Lung Disease, Antibiotics +11

Spray Dried Powders and Powder Blends of Recombinant Human Deoxyribonuclease (rhDNase) for Aerosol Delivery

Hak‐Kim Chan, Igor Gonda, Marco Mumenthaler et al. · Pharmaceutical Research · 1997 · 140 citations

Pharmacokinetics and Pharmacodynamics of Inhaled  versus Intravenous Morphine in Healthy Volunteers 

Mark Dershwitz, J. Walsh, Richard Morishige et al. · Anesthesiology · 2000 · 138 citations · Full text